These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30278482)

  • 21. Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis.
    Tian Y; Ma Z; Chen Z; Li M; Wu Z; Hong M; Wang H; Svatek R; Rodriguez R; Wang Z
    PLoS One; 2016; 11(7):e0158891. PubMed ID: 27410033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
    Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
    Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress.
    Kuehnle K; Crameri A; Kälin RE; Luciani P; Benvenuti S; Peri A; Ratti F; Rodolfo M; Kulic L; Heppner FL; Nitsch RM; Mohajeri MH
    Mol Cell Biol; 2008 Jan; 28(2):539-50. PubMed ID: 17984220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer.
    Bonaccorsi L; Luciani P; Nesi G; Mannucci E; Deledda C; Dichiara F; Paglierani M; Rosati F; Masieri L; Serni S; Carini M; Proietti-Pannunzi L; Monti S; Forti G; Danza G; Serio M; Peri A
    Lab Invest; 2008 Oct; 88(10):1049-56. PubMed ID: 18762779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression level of BLCA-4 correlates with poor prognosis in human bladder cancer.
    Zhao Q; Shen WH; Chen ZW; Zhou ZS; Ji HX
    Int J Clin Exp Pathol; 2012; 5(5):422-7. PubMed ID: 22808294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
    Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
    Tang K; Wang C; Chen Z; Xu H; Ye Z
    Int J Clin Exp Pathol; 2015; 8(5):4999-5007. PubMed ID: 26191193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation of DHCR24 expression by hepatitis C virus infection facilitates viral replication in hepatocytes.
    Takano T; Tsukiyama-Kohara K; Hayashi M; Hirata Y; Satoh M; Tokunaga Y; Tateno C; Hayashi Y; Hishima T; Funata N; Sudoh M; Kohara M
    J Hepatol; 2011 Sep; 55(3):512-521. PubMed ID: 21184787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
    Zhu X; Qiao Y; Liu W; Wang W; Shen H; Lu Y; Hao G; Zheng J; Tian Y
    Tumour Biol; 2016 Apr; 37(4):4569-77. PubMed ID: 26503215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive androstane receptor transactivates the hepatic expression of mouse Dhcr24 and human DHCR24 encoding a cholesterogenic enzyme 24-dehydrocholesterol reductase.
    Yoshinari K; Ohno H; Benoki S; Yamazoe Y
    Toxicol Lett; 2012 Jan; 208(2):185-91. PubMed ID: 22101211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal DHCR24 down regulation in a rat model of streptozotocin-induced cognitive decline.
    Hosseinzadeh S; Zahmatkesh M; Heidari M; Hassanzadeh GR; Karimian M; Sarrafnejad A; Zarrindast MR
    Neurosci Lett; 2015 Feb; 587():107-12. PubMed ID: 25541351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive Review.
    Fu X; Wang Z
    Technol Cancer Res Treat; 2024; 23():15330338241259780. PubMed ID: 38847653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
    Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.
    Zhao X; Ji Z; Xie Y; Liu G; Li H
    Oncol Rep; 2017 Nov; 38(5):2727-2734. PubMed ID: 29048677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD147 Expression Is Associated with Tumor Proliferation in Bladder Cancer via GSDMD.
    Peng J; Jiang H; Guo J; Huang J; Yuan Q; Xie J; Xiao K
    Biomed Res Int; 2020; 2020():7638975. PubMed ID: 32149134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells.
    Miao X; Gao H; Liu S; Chen M; Xu W; Ling X; Deng X; Rao C
    Int J Biol Macromol; 2018 Jan; 106():234-240. PubMed ID: 28780419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
    Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
    Hu H; Chen Y; Cheng S; Li G; Zhang Z
    Wien Klin Wochenschr; 2017 Jun; 129(11-12):391-397. PubMed ID: 27830363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.
    Tschirdewahn S; Reis H; Niedworok C; Nyirady P; Szendröi A; Schmid KW; Shariat SF; Kramer G; vom Dorp F; Rübben H; Szarvas T
    Urol Oncol; 2014 Jul; 32(5):663-9. PubMed ID: 24814404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.